HomeICLR • NASDAQ
add
ICON PLC
Previous close
$320.58
Day range
$314.07 - $322.47
Year range
$221.27 - $347.72
Market cap
26.67B USD
Avg Volume
450.68K
P/E ratio
37.43
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.12B | 4.95% |
Operating expense | 345.09M | 2.69% |
Net income | 146.91M | 27.09% |
Net profit margin | 6.93 | 21.15% |
Earnings per share | 3.75 | 20.58% |
EBITDA | 432.10M | 7.25% |
Effective tax rate | 13.71% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 506.55M | 86.35% |
Total assets | 16.97B | -0.81% |
Total liabilities | 7.38B | -11.16% |
Total equity | 9.59B | — |
Shares outstanding | 82.82M | — |
Price to book | 2.77 | — |
Return on assets | 4.15% | — |
Return on capital | 5.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 146.91M | 27.09% |
Cash from operations | 218.59M | 7.21% |
Cash from investing | -34.20M | 15.79% |
Cash from financing | -71.75M | 58.47% |
Net change in cash | 110.47M | 1,238.41% |
Free cash flow | 186.87M | 0.04% |
About
ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries. Wikipedia
CEO
Founded
1990
Website
Employees
41,100
